Haleon Plc(HLN-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low9.22
Day High9.31
Open:9.26
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
the globe and mail
Mark Hornick, President and CEO of Jamieson Wellness Inc., checks out his product in the vitamin isle of a pharmacy in Toronto, Ontario, Canada, on Tuesday, February 25, 2020. /Aaron Vincent Elkaim for The Globe and Mail
the globe and mail

Jamieson Wellness in talks with a potential buyer after receiving an unsolicited takeover offer

Analysts expect a deal for the vitamin maker could be worth more than $2-billion
Tipranks
J.P. Morgan Reaffirms Their Sell Rating on Haleon PLC (HLN)
Tipranks
Barclays Reaffirms Their Buy Rating on Haleon PLC (HLN)
Tipranks
Haleon Advances Pediatric Pain Relief Combo With New Phase I Study
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO) and Haleon PLC Sponsored ADR (HLN)
GlobeNewswire
‘For The Assist’: Haleon Canada launches national campaign with Canada Soccer to celebrate the small health supports behind Canadian wellbeing
Tipranks
Bernstein Reaffirms Their Hold Rating on Haleon PLC (HLN)
Tipranks
Haleon PLC (HLN) Gets a Buy from Barclays
Tipranks
Jefferies Reaffirms Their Buy Rating on Haleon PLC (HLN)
GlobeNewswire
Centrum Launches Newly Reformulated Adults 50+ Complete Multivitamin with Clinically Shown Cognitive Benefits
Tipranks
Kepler Capital Sticks to Its Buy Rating for Haleon PLC (HLN)
Tipranks
Berenberg Bank Sticks to Its Buy Rating for Haleon PLC (HLN)
Tipranks
UBS Reaffirms Their Buy Rating on Haleon PLC (HLN)
Tipranks
Haleon PLC (HLN) Gets a Buy from Goldman Sachs
Tipranks
Barclays Sticks to Its Buy Rating for Haleon PLC (HLN)
Tipranks
Haleon’s New Dentin Sensitivity Study Signals Long‑Term Focus on Real‑World Oral Health
Tipranks
Haleon PLC (HLN) Receives a Buy from Kepler Capital
Tipranks
Haleon’s New Sensitivity Toothpaste Trial in China: What Investors Should Watch
Tipranks
UBS Remains a Buy on Haleon PLC (HLN)
Tipranks
Barclays Remains a Buy on Haleon PLC (HLN)

Profile

Haleon plc engages in the research and development, manufacture and sale of various consumer healthcare products principally in North America, Europe, the Middle East, Africa, Latin America and the Asia Pacific. It provides therapeutic oral health, pain relief, respiratory health, digestive health and other products, as well as vitamins, minerals and supplements. Haleon plc is based in Brentford, the United Kingdom.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.